Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease
This large-scale cohort study found that the use of an FPS was not associated with lower risk of death or hospitalization from any cause. However, the results generated a clinically important hypothesis that FPS use may be associated with slightly lower risk of death among older patients with chronic cardiovascular or endocrine disease.
Authors
- Ryo Iketani
- Shinobu Imai (ORCID: https://orcid.org/0000-0003-1784-5133)
Institutions
- SHOWA Medical University (JP)
- Showa Pharmaceutical University (JP)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.60398
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science